{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:37:20Z","timestamp":1791308240885,"version":"4.3.1"},"reference-count":28,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC Centre of Research Excellence","doi-asserted-by":"publisher","award":["GNT1198902"],"award-info":[{"award-number":["GNT1198902"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"award":["GNT1198902"],"award-info":[{"award-number":["GNT1198902"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Objective: To identify demographic, clinical, and behavioural determinants of COVID-19 vaccination and antiviral uptake in Australia using the Capability, Opportunity, Motivation-Behaviour (COM-B) framework with psychometric validation and LASSO-enhanced variable selection. Methods: Cross-sectional analysis of the 2024 KAB BREATHE survey (n = 5177) of Australian adults, intentionally enriched for risk-stacked (more than 1 chronic condition). Primary outcomes included 2023\/2024 COVID-19 booster receipt, future vaccine intentions, vaccine\/antiviral beliefs and antiviral uptake. Predictors included demographics, chronic conditions, and domain-specific leave-one-out (LOO) COM-B scores standardised to mean = 0, SD = 1. COM-B domains were assessed using Cronbach\u2019s alpha. Univariate and multivariable logistic regression models were complemented by LASSO penalised logistic regression with 10-fold cross-validation. Results: Among 5177 Australian adults, the mean age was 51.5 years (SD 16.5), 61.4% (3179\/5177) were female, and 70.3% (3638\/5177) were classified as risk-stacked. Booster uptake declined sharply from 50.8% (2023) to 19.1% (2024). Cronbach\u2019s alpha showed poor internal consistency for Capability (\u03b1 = 0.006) and Opportunity (\u03b1 = \u22120.383) but was acceptable for full Motivation (\u03b1 = 0.78). In adjusted models, age (aOR 1.02\u20131.03 per year), medically associated risk factors (aOR 1.66\u20133.51), and tertiary education (aOR 1.34\u20131.79) consistently predicted higher uptake and intention. Renting (aOR 0.59\u20130.78) and current employment (likely inversely associated with age) (aOR 0.73\u20130.83) were associated with lower uptake across all vaccine outcomes. Adding LOO COM-B scores substantially improved model fit (e.g., 2024 booster AUC 0.73\u21920.83); Motivation per SD was the strongest predictor (aOR 2.44\u20134.94 for vaccine outcomes, 1.52\u20132.49 for antivirals). LASSO models achieved CV-AUCs of 0.78\u20130.87. Among COVID-positive respondents (n = 2576), only 15.2% received antiviral treatment. Conclusions: Age, clinical risk, and socioeconomic factors, particularly housing tenure and employment status, are key drivers of COVID-19 preventive behaviours (either positively or negatively). The COM-B framework, when corrected for circular prediction and validated via Cronbach\u2019s alpha and LASSO, provides substantial explanatory value. Targeted interventions should address structural barriers faced by renters and younger, employed individuals while leveraging high motivation among older adults and clinically vulnerable groups. Implications for Public Health: These findings support a shift from knowledge-based campaigns towards equity-focused, multi-level public health strategies that address structural barriers to COVID-19 vaccination and antiviral access in Australia.<\/jats:p>","DOI":"10.3390\/vaccines14060495","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:45:08Z","timestamp":1780404308000},"page":"495","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Behavioural Drivers of COVID-19 Vaccination and Antiviral Uptake in Australia: A Cross-Sectional Analysis Using the COM-B Framework"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4915-5518","authenticated-orcid":false,"given":"Stephen","family":"Wiblin","sequence":"first","affiliation":[{"name":"School of Population Health, University of New South Wales, Sydney, NSW 2000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohana","family":"Kunasekaran","sequence":"additional","affiliation":[{"name":"Kirby Institute, University of New South Wales, Kensington, NSW 2000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raina","family":"MacIntyre","sequence":"additional","affiliation":[{"name":"Kirby Institute, University of New South Wales, Kensington, NSW 2000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Seale","sequence":"additional","affiliation":[{"name":"School of Population Health, University of New South Wales, Sydney, NSW 2000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4161\/hv.24657","article-title":"Vaccine hesitancy: An overview","volume":"9","author":"Laberge","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: Definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: A new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Patterson, L., Berry, E., Parsons, C., Clarke, B., Little, A., Beggs, J., Chuter, A., Jackson, T., Hsia, Y., and McGrath, H. (2023). Using the COM-B framework to elucidate facilitators and barriers to COVID-19 vaccine uptake in pregnant women: A qualitative study. BMC Pregnancy Childbirth, 23.","DOI":"10.1186\/s12884-023-05958-y"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100276","DOI":"10.1016\/j.jvacx.2023.100276","article-title":"Psychosocial factors affecting COVID-19 vaccine uptake in the UK: A prospective cohort study (CoVAccS\u2014Wave 3)","volume":"13","author":"Smith","year":"2023","journal-title":"Vaccine X"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/tbm\/ibaa116","article-title":"What the guide does not tell you: Reflections on and lessons learned from applying the COM-B behavior model for designing real life interventions","volume":"11","author":"Whittal","year":"2021","journal-title":"Transl. Behav. Med."},{"key":"ref_7","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI) (2026, April 12). ATAGI Statement on Administration of COVID-19 Vaccines in 2024. Department of Health, Disability and Ageing, Available online: https:\/\/www.health.gov.au\/resources\/publications\/atagi-statement-on-the-administration-of-covid-19-vaccines-in-2024?language=en."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5694\/mja2.51949","article-title":"Access to oral COVID-19 antivirals in the community","volume":"218","author":"Allard","year":"2023","journal-title":"Med. J. Aust."},{"key":"ref_9","unstructured":"Australian Bureau of Statistics (2026, April 12). National Health Survey: Chronic Conditions, 2022\u201323, Available online: https:\/\/www.abs.gov.au\/statistics\/health\/health-conditions-and-risks\/national-health-survey\/latest-release#health-conditions."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.amepre.2022.05.013","article-title":"COVID-19 Vaccination and Intent for Vaccination of Adults with Reported Medical Conditions","volume":"63","author":"Lu","year":"2022","journal-title":"Am. J. Prev. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41591-021-01381-y","article-title":"Health systems resilience in managing the COVID-19 pandemic: Lessons from 28 countries","volume":"27","author":"Haldane","year":"2021","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","article-title":"Making sense of Cronbach\u2019s alpha","volume":"2","author":"Tavakol","year":"2011","journal-title":"Int. J. Med. Educ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjhp.12417","article-title":"Acceptability, reliability, and validity of a brief measure of capabilities, opportunities, and motivations (\u201cCOM-B\u201d)","volume":"25","author":"Keyworth","year":"2020","journal-title":"Br. J. Health Psychol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Edwards, B., Biddle, N., Gray, M., and Sollis, K. (2021). COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248892"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e057127","DOI":"10.1136\/bmjopen-2021-057127","article-title":"Attitudes towards vaccines and intention to vaccinate against COVID-19: A cross-sectional analysis\u2014Implications for public health communications in Australia","volume":"12","author":"Enticott","year":"2022","journal-title":"BMJ Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e70025","DOI":"10.1111\/hex.70025","article-title":"Attitudes and behaviours regarding COVID-19 mitigation strategies in Australians with an underlying health condition: A cross-sectional study","volume":"27","author":"Soh","year":"2024","journal-title":"Health Expect."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Williams, C.T., Saini, B., Zaidi, S.T.R., Kali, C., Moujalli, G., and Castelino, R. (2024). Factors influencing COVID-19 vaccine confidence and uptake in Australian adults. Vaccines, 12.","DOI":"10.3390\/vaccines12060627"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10852352.2016.1197714","article-title":"Poor housing quality: Prevalence and health effects","volume":"44","author":"Baker","year":"2016","journal-title":"J. Prev. Interv. Community"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/aje\/kwr161","article-title":"Association between housing affordability and mental health: A longitudinal analysis of a nationally representative household survey in Australia","volume":"174","author":"Bentley","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Doherty, I.A., Pilkington, W., Brown, L., Billings, V., Hoffler, U., Paulin, L., Kimbro, K.S., Baker, B., Zhang, T., and Locklear, T. (2021). COVID-19 vaccine hesitancy in underserved communities of North Carolina. PLoS ONE, 16.","DOI":"10.1101\/2021.02.21.21252163"},{"key":"ref_21","first-page":"2167","article-title":"A worldwide assessment of COVID-19 pandemic-policy fatigue","volume":"398","author":"Petherick","year":"2021","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","article-title":"A global survey of potential acceptance of a COVID-19 vaccine","volume":"27","author":"Lazarus","year":"2021","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1080\/21645515.2020.1846397","article-title":"COVID-19 vaccination intention in the UK: Results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey","volume":"17","author":"Sherman","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Nga, N.T.V., Xuan, V.N., Trong, V.A., Thao, P.H., and Doanh, D.C. (2023). Perceived Barriers and Intentions to Receive COVID-19 Vaccines: Psychological Distress as a Moderator. Vaccines, 11.","DOI":"10.3390\/vaccines11020289"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Betsch, C., Schmid, P., Heinemeier, D., Korn, L., Holtmann, C., and B\u00f6hm, R. (2018). Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE, 13.","DOI":"10.31234\/osf.io\/ytb7w"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"n513","DOI":"10.1136\/bmj.n513","article-title":"COVID-19 vaccine hesitancy among ethnic minority groups","volume":"372","author":"Razai","year":"2021","journal-title":"BMJ"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kleitman, S., Fullerton, D.J., Law, M.K.H., Blanchard, M.D., Campbell, R., Tait, M.-A., Schulz, J., Lee, J., Stankov, L., and King, M.T. (2023). The Psychology of COVID-19 Booster Hesitancy, Acceptance and Resistance in Australia. Vaccines, 11.","DOI":"10.3390\/vaccines11050907"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Oyegun, E., Ategbole, M., Jorgensen, C., Fisher, A., Briggs, M.H., Gutekunst, L., Roberts, E., and Koumans, E.H. (2025). Factors associated with knowledge, attitudes, and behaviors regarding antiviral medications for COVID-19 among US adults. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0335182"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/6\/495\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:23:10Z","timestamp":1780406590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/6\/495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["vaccines14060495"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14060495","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,31]]}}}